Global Measles and other Vaccine Preventable Disease Activities | CDC RFA GH17 1701

Opportunity Information: Apply for CDC RFA GH17 1701

This funding opportunity, titled "Global Measles and other Vaccine Preventable Disease Activities" (Funding Opportunity Number: CDC RFA GH17-1701), is a CDC-led cooperative agreement designed to support international measles and rubella control and elimination efforts, with a strong operational focus on helping priority countries access the tools and expertise needed to reduce transmission and move toward elimination. The program centers on facilitating the provision of measles-containing vaccine (MCV) and measles-and-rubella-containing vaccine (MRCV), along with the practical support systems that make vaccination campaigns safe, feasible, and effective in real-world settings.

A key feature of the announcement is its emphasis on providing "bundled" vaccine. In this context, bundled means the vaccine itself plus the associated injection supplies and waste-management materials required for safe delivery, including the items needed to ensure safe injections and the safe disposal of vaccine vials and used injection materials. This framing highlights that success is not just about purchasing doses, but also about ensuring that countries can administer them safely at scale and manage medical waste appropriately, which is essential for maintaining public trust, preventing needle-related harms, and meeting basic infection prevention standards.

The activities supported under the award span several core technical areas. One major component is vaccine procurement and maintaining global availability of supply, meaning the effort is not limited to buying vaccines for a single setting but also considers broader supply reliability and access for countries that are prioritized for measles and rubella control. Another major component is surveillance, specifically to better define and assess which countries remain endemic for measles and rubella and to track progress and gaps over time. Strong surveillance is positioned as a foundational requirement because elimination goals depend on timely case detection, accurate classification of transmission patterns, and the ability to rapidly identify outbreaks and immunity gaps.

The opportunity also prioritizes laboratory capacity, including building and strengthening a global laboratory network capable of measles and rubella serologic diagnosis and virus isolation, particularly in developing countries. This laboratory network element is important because confirming cases, differentiating measles from rubella and other rash illnesses, and characterizing virus strains are central to understanding transmission dynamics, documenting interruption of endemic transmission, and guiding targeted responses. Laboratory confirmation and standardized testing networks also help ensure that surveillance data is comparable across countries and over time.

In addition, the announcement supports direct assistance to foreign governments in planning and implementing large-scale immunization activities such as national immunization days, along with other measles and rubella control interventions. This includes programmatic support and the use of technical experts and consultants as needed, reflecting that the work often requires specialized planning for logistics, cold chain management, campaign microplanning, social mobilization, data management, and post-campaign evaluation. The cooperative agreement structure implies active collaboration with CDC rather than a purely hands-off grant, with CDC and the recipient coordinating to deliver agreed-upon technical and operational outcomes.

While the main emphasis is measles and rubella, the FOA also allows, as agreed by CDC and the United Nations Foundation (UNF), support for efforts that strengthen routine immunization (RI) delivery systems and capacity in developing countries. This is presented as a way to help countries reach globally agreed vaccine-preventable disease goals across control, elimination, and eradication initiatives. In practice, this signals that the award can support not only campaign-style vaccination pushes but also improvements to the underlying immunization system that sustains high coverage over time, which is critical to preventing resurgence after campaigns end.

From an administrative standpoint, the opportunity is categorized as discretionary funding and uses a cooperative agreement instrument. It falls under the health funding activity category and lists CFDA number 93.318. Eligible applicants include nonprofit organizations with 501(c)(3) status (excluding institutions of higher education), nonprofits without 501(c)(3) status (also excluding institutions of higher education), and other eligible entities as defined by the announcement. The issuing agency is the Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH). The posting indicates an expected number of awards of one, suggesting a single primary awardee to coordinate and deliver the package of procurement and technical assistance activities. The original closing date listed is March 15, 2017, and the record creation date is December 12, 2016. The United Nations Foundation is referenced with an address in Washington, DC, indicating a role tied to coordination or implementation arrangements described in the opportunity.

• The Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Global Measles and other Vaccine Preventable Disease Activities" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.318.
• This funding opportunity was created on 2016-12-12.
• Applicants must submit their applications by 2017-03-15. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Others.

Apply for CDC RFA GH17 1701

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: